Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Jose Urquidy

Tigers Notes: Vierling, Olson, Urquidy, Boyd

By | at

A right rotator cuff strain delayed Matt Vierling’s season debut until May 23, and he played in only four games before inflammation in that same right shoulder sent him back to the injured list.  The Tigers utilityman’s luck may be starting to change, however, as a visit with Dr. Keith Meister earlier this week resulted in what Vierling described as “absolutely the best-case scenario” of just inflammation.

“I was nervous it might be something more serious, but the MRI showed that everything was fine structurally….I will start throwing [Sunday] and build up from there.  There is no exact timeline but hopefully sooner than later,” Vierling told the Detroit News’ Chris McCosky and other reporters yesterday.  Vierling also noted that he received an injection in his shoulder during his appointment.

Vierling is the only position player on the Tigers’ injured list, after a swath of early-season injuries left the club heavily depleted in the outfield.  Parker Meadows and Wenceel Perez have now both returned from the IL, Zach McKinstry remains a Swiss Army knife around the diamond, and Javier Baez has also evolved from a shortstop into more of a utility player (and a part-time center fielder).

All that’s missing now is Vierling, who filled a multi-positional role for Detroit in 2023-24 by suiting up at third base and at all three outfield positions, as well as a couple of appearances at first and second base.  Vierling also hit a respectable .259/.320/.406 over 1097 plate appearances over those two seasons, and his right-handed bat can help balance out a Tigers lineup that is still heavy in left-handed hitters.

Turning to the pitching side of the injured list, Tigers manager A.J. Hinch provided McCosky and company with an update on Reese Olson’s status.  Olson received an injection in his inflamed right ring finger last Wednesday, and threw a bullpen session on Saturday.  The next step will be incorporating changeups in Olson’s throwing sessions and future bullpens, which is the key step since it was throwing the changeup that led to the inflammation in the first place.

Olson increased his changeup usage this season, throwing the pitch 25.3% of the time and making it his chief secondary offering behind his sinker (31%).  An average pitch for Olson over his first two MLB seasons, the changeup was now suddenly his most effective offering as per Statcast’s run value metric, with the changeup registering a +5 this year.  This was, of course, over the small sample size of 48 2/3 innings in 2025, and the increase in effectiveness came at a price in the form of this IL trip.  Olson hasn’t pitched since May 17, and it looks like he’ll continue to be sidelined into the second half of June.

Jose Urquidy won’t be a factor (if at all) for the Tigers until much later in the 2025 season, as the right-hander is almost exactly one year removed from a Tommy John surgery.  Urquidy inked a one-year, $1MM guaranteed deal with Detroit in March that gives the Tigers a $4MM club option for 2026, essentially making this season a wait-and-see scenario for the team in gauging Urquidy’s recovery from rehab.

Urquidy hit a big checkpoint in his process on Friday, as Hinch said the righty threw a bullpen session at the Tigers’ spring complex in Lakeland.  Many steps remain in the throwing progression, and McCosky writes that “Urquidy is still maybe a month or more away from a rehab assignment.”  If all goes well, Urquidy could possibly be a factor for Detroit in late August or September, which would allow him to at least bank a few MLB innings as a bridge towards a fully healthy 2026.

With the Cubs visiting Detroit for a series, former Tiger Matthew Boyd was in town reuniting with some old friends in the clubhouse and on the media beat.  Boyd was a free agent this last winter, and he told MLive.com’s Evan Woodbery that he had some talks with the Tigers about a possible deal before eventually going to Chicago on a two-year, $29MM contract.  That signing has worked out wonderfully thus far, as Boyd has a 3.10 ERA over 68 2/3 innings and has been a stabilizing force within the Cubs’ injury-riddled rotation.

Boyd has spent eight of his 11 MLB seasons in a Detroit uniform, though the second of his two stints with the Tigers didn’t end well.  The southpaw signed a one-year, $10MM deal with the Tigers during the 2022-23 offseason, but he produced only a 5.45 ERA over 71 innings before a Tommy John surgery ended his 2023 season and kept him on the shelf for most of the 2024 campaign.  Boyd was able to return by the end of 2024 and, as a member of the Guardians, looked very sharp in posting a 2.72 ERA in 39 2/3 regular-season innings and then an 0.77 ERA over 11 2/3 postseason frames.

That performance was enough to land Boyd two guaranteed years from the Cubs, plus the contract contains a mutual option for 2027.  It is possible that giving Boyd a second year was too much for the Tigers, as the club was focused mostly on shorter-term additions to its pitching staff.  Detroit brought Jack Flaherty (for two years and $35MM, with an opt-out after 2025) and Alex Cobb (one year, $15MM) into the fold this past winter as alternatives to another reunion with Boyd.

Looking Ahead To Club Options: AL Central

By | at

MLBTR continues our division by division look at next year’s team/mutual option class with the AL Central. Virtually all of the mutual options will be bought out by one side. Generally, if the team is willing to retain the player at the option price, the player will decline his end in search of a better free agent deal.

Previous installments: player options/opt-outs, NL West, AL West, NL Central

Chicago White Sox

Pérez signed a $5MM free agent deal to serve as the veteran presence in a very young White Sox rotation. Chicago hoped he’d pitch well enough in the first half to net a lottery ticket prospect at the deadline. Pérez was reasonably effective through his first three starts, but he came out of his fourth outing with forearm discomfort. A flexor strain diagnosis immediately sent him to the 60-day injured list. He’s expected to avoid surgery but will miss almost the entire season. A deadline trade is off the table, and he’ll be bought out at season’s end.

As recently as a few months ago, Robert’s $20MM club option looked like excellent value, as did the matching option for 2026. He was a down-ballot MVP performer in 2023, when he hit .264/.315/.542 with 38 homers while playing plus center field defense. The ’24 campaign was a struggle. Robert missed nearly two months early in the season with a hip flexor strain and was unproductive when healthy. He hit .224/.278/.379 with 14 homers in 100 games. Chicago held him into this year rather than sell low in an offseason trade.

That put a lot of pressure on Robert to hit early in the year. An excellent few months could make him one of the top position players available at the deadline. A terrible start might tank what remained of his trade value. The early returns are disastrous: .138/.255/.238 with 30 strikeouts in 96 plate appearances. There’s still time for a turnaround, but Robert may be following in the footsteps of Tim Anderson and Eloy Jiménez — players whose once team-friendly extensions soured to the point that they were traded for meager returns and/or bought out.

Cleveland Guardians

Means underwent UCL surgery last June. That was his second such procedure within the past three years. He’d undergone Tommy John surgery in 2022 and had only just returned before his elbow gave out again. The Guardians took a $1MM flier in free agency. The deal includes a $6MM team option for next season. Means is hoping to return to the mound in August or September. His late-season form will determine whether Cleveland wants to keep him around next year.

If the Guardians exercise the option, Means could unlock up to $2.5MM in performance bonuses. He’d earn $75K apiece at 20, 30, 40 and 50 innings pitched next year. That climbs to $100K each for 60, 70, 80 and 90 frames; $125K at 100, 110, 120 and 130 innings; and $150K apiece for 140 and 150 frames.

Sewald had a pair of above-average seasons as Seattle’s closer between 2022-23. His production started to trend down after a ’23 deadline deal that sent him to Arizona. Sewald remained generally productive through the Snakes’ surprising World Series run that year. Last season was his worst since his 2021 breakout. He allowed a 4.31 ERA with declining velocity through 39 2/3 innings. The Guardians surprisingly guaranteed him $7MM to deepen an already excellent bullpen. The veteran righty has punched out 13 hitters through 10 1/3 frames, but he has already surrendered three homers while averaging just 90.2 MPH on his fastball.

Detroit Tigers

Detroit added Brebbia on a $2.75MM contract early in Spring Training. It was a roll of the dice on the veteran righty’s intriguing swing-and-miss rates. Brebbia had allowed nearly six earned runs per nine innings last season (mostly with the White Sox), but he punched out nearly 28% of opposing hitters. Things have reversed early in his Detroit tenure. Brebbia has only allowed two runs (one earned) over his first nine innings. His 8.8% swinging strike rate is well below average, though, and he’s given out eight free passes — five walks and three hit batters.

Brebbia is working in low-leverage situations that suggest he’s towards the bottom of the bullpen depth chart. He’ll need to turn around his underlying numbers to pitch his way into more meaningful spots and, eventually, to convince the front office to exercise the option.

Brebbia could push the option price by another $4MM based on his performance this year. It’d climb by $500K at 65 appearances, $1MM apiece at 45 and 50 games finished, and by $2MM for 55 games finished. The maximum escalator value is capped at $4MM, so the appearance threshold would essentially be nullified if Brebbia finishes 55 games and pushes the option value to $8MM based on that criteria alone. He has finished six of eight appearances so far.

Urquidy’s situation is similar to that of Means. The former Astros righty required Tommy John surgery last June. Houston waived him at the end of the season. He reunited with A.J. Hinch in Detroit on a $1MM contract. Urquidy won’t be an option until the final few weeks of the season in a best case scenario. Detroit can gauge his progress to determine whether they want to retain him at a $4MM base value. Urquidy could tack on another $3MM if the Tigers exercise the option: $150K each at four and seven starts next year; $300K apiece for 10, 13, 16 and 19 starts; and $500K each at 22, 25 and 28 starts.

Kansas City Royals

  • Michael Lorenzen, RHP ($12MM mutual option, $1.5M buyout if team declines its end)

Kansas City brought Lorenzen back on a $7MM free agent deal. He’s playing on a $5.5MM salary and would collect a $1.5MM buyout on a $12MM mutual option assuming the Royals decline their end. He grabbed a season-opening rotation spot with both Alec Marsh and Kyle Wright on the shelf. Lorenzen has had a customary start to the season. He carried a 4.57 ERA with a below-average 17.7% strikeout rate into this evening’s appearance against the Rockies. He’s through five scoreless innings against Colorado at the time of this writing.

Perez is making $22MM in the final season of the four-year extension that he signed in March 2021. At the time, it was the largest contract in organizational history. (Bobby Witt Jr. has since shattered that record.) Perez is a franchise stalwart, of course, but it was still surprising to see the Royals guarantee him $82MM for his age 32-35 seasons — especially given the heavy workloads he’d taken throughout his career.

The nine-time All-Star has rewarded the team’s faith. He led the majors with 48 homers and 121 RBI in 2021, though he was already under contract for that season anyhow. He combined for a .261/.307/.447 slash over the first three seasons of the extension. Perez eclipsed 20 home runs in each, and he won the AL Silver Slugger Award behind the dish with a .271/.330/.456 showing during last year’s playoff season.

Perez has started this season more slowly. He entered today’s doubleheader with a .185/.235/.293 line, though he has picked up four doubles over two games against Colorado pitching. If this continues all season, the Royals could face a tough decision, but the safer bet right now is that Kansas City will exercise the option. It’s tough to imagine Perez playing anywhere else.

Minnesota Twins

Minnesota added Bader on a $6.25MM contract amidst a quiet offseason. They’ve preferred to have a capable right-handed hitting fourth outfielder who can reduce Byron Buxton’s workload in center field while complementing their lefty-hitting corner bats. Bader has started 18 of the team’s first 25 games. He’s hitting .230/.319/.393 with a trio of home runs through 69 plate appearances. It’s an early improvement over last year’s .236/.284/.373 showing, but it’s unlikely the Twins would exercise their end of a $10MM option.

The bigger factor might be Bader’s semi-regular playing time. He could push the buyout price as high as $3MM based on this season’s plate appearance total. It has a $1.5MM base value and would climb by $200K at 400, 425 and 450 plate appearances, then by $450K at 475 and 500.

Note: Justin Topa’s arbitration contract contains a $2MM club option or a $225K buyout for next season. He’d remain eligible for arbitration if the team declines the option, as he will not have reached six years of service time.

Tigers Sign José Urquidy

By | at

The Tigers have signed free agent right-hander José Urquidy to a one-year, $1MM contract for 2025, the team announced. The deal comes with a $4MM team option for 2026. That team option also includes escalators that could increase Urquidy’s salary by up to $3MM. He will earn an additional $150K for reaching each of four and seven starts; $300K for reaching each of 10, 13, 16, and 19 starts; and $500K for reaching each of 22, 25, and 28 starts.

To free up space for Urquidy on the 40-man roster, the Tigers placed fellow right-hander Sawyer Gipson-Long on the 60-day injured list while he continues to recover from left hip labral repair and Tommy John surgery. The team has also placed Urquidy on the 60-day IL; he is recovering from Tommy John surgery of his own.

Urquidy spent the first six years of his MLB career with the Astros. While he looked like a solid mid-rotation starter in 2021 and ’22 (3.81 ERA, 4.22 SIERA in 49 games), the righty had a rough year in 2023. He struggled out of the gate in April before landing on the IL with shoulder troubles. His struggles continued upon his return in August, and he soon lost his spot in the starting rotation.

Unfortunately, Urquidy’s troubles only got worse in 2024. He opened the season on the injured list and eventually required UCL surgery in June. After clearing waivers in November, he elected free agency.

Urquidy will not be ready to return to action until midseason at the earliest, so he will not factor into the ongoing rotation battle in Tigers camp. Tarik Skubal, Jack Flaherty, and Reese Olson are locks for the Opening Day rotation, and top prospect Jackson Jobe has the inside track on the number four spot, according to Evan Petzold of the Detroit Free Press. However, with Alex Cobb expected to miss the beginning of the season, one spot at the back end is still up for grabs. Casey Mize, Kenta Maeda, and Keider Montero are the primary candidates to win that job.

Meanwhile, Urquidy will continue his rehab in the Tigers organization. Once he is ready to get back on the field, he can provide depth as a back-end starter or long reliever. In a best-case scenario, Urquidy returns and looks like his old self, which would make his club option for 2026 a bargain. Meanwhile, the worst possible outcome for the Tigers is that they pay him $1MM to rehab in 2025 and cut their losses at the end of the year if he struggles or fails to get back on the mound.

Ari Alexander of KPRC 2 was the first to report the agreement between Urquidy and the Tigers. Chris McCosky of the Detroit News confirmed that it was a major league deal.

José Urquidy Clears Waivers And Becomes Free Agent

By | at

The Astros have sent right-hander José Urquidy through outright waivers and he is now a free agent, per Chandler Rome of The Athletic on X. The same is true of fellow righty Oliver Ortega, who was also outrighted and became a free agent.

Urquidy, 30 in May, has tossed 405 innings for the Astros in his career with a 3.98 earned run average, 19.6% strikeout rate and 5.8% walk rate. Unfortunately, he underwent Tommy John surgery in June and is therefore slated to miss most or all of the 2025 campaign.

That was going to be his final season of club control, with the Astros eligible to retain him via arbitration. MLBTR contributor Matt Swartz projected Urquidy for a $3.75MM salary next year but the Astros seemingly decided it wasn’t worth making that kind of investment for a player with such an uncertain timeline and bumped him off the roster instead. All of the other clubs seemingly agreed with none of them putting in a claim. As a player with at least three years of service time, Urquidy has the right to elect free agency instead of accepting an outright assignment.

Urquidy will now head to the open market and perhaps head to a new club for the first time. Pitchers recovering from Tommy John surgeries can sometimes find two-year deals that cover the rehab portion and also give the signing club an extra year of club control wherein the pitcher is hopefully fully healthy.

Ortega, 28, was claimed off waivers from the Twins a year ago but never got to pitch for the Astros. He underwent surgery in March to remove loose bodies from his elbow and then underwent another surgery in June to remove a bone spur. Due to those surgeries, he spent the entire season on the injured list. His current status is unclear but the Astros didn’t want to keep him on the roster going forward. As a player with a previous career outright, he had the right to elect free agency and did so.

Astros Place Kyle Tucker On Injured List

By | at

11:30pm: Houston will recall Joey Loperfido to take Tucker’s place on the active roster, reports Brian McTaggart of MLB.com (on X). Loperfido debuted earlier this season and hit .333/.381/.436 with a homer in 14 games.

8:36pm: The Astros have placed star outfielder Kyle Tucker on the 10-day injured list with a right shin contusion, tweets Matt Kawahara of the Houston Chronicle. The move is retroactive to June 4, meaning Tucker could return a week from now. Houston didn’t immediately announce a corresponding roster move or provide a timetable for his return.

Tucker was injured in Monday’s win over the Cardinals. He fouled a ball off his leg and had to be removed from the game. While the two-time All-Star was on crutches postgame, testing didn’t reveal any fractures. That led the Astros to keep him on the active roster for a few days even though he wasn’t healthy enough to play. He evidently needed more time than the team initially hoped, sending him to the shelf.

It’s probably no coincidence that Houston placed Tucker on the IL just before tonight’s game. A team is allowed to backdate an IL stint by up to three days. Tucker had already been out since June 4. If the Astros had waited into the weekend to put him on the shelf, they’d have pushed back his first possible return date.

The injury halts a fantastic start to the season. Tucker has been a superstar for a few years and has taken his game to new heights in 2024. He has already hit 19 homers across 262 plate appearances. He’s running a .266/.395/.584 batting line with 46 walks against 41 strikeouts over 60 games. If healthy, he should coast to a third consecutive All-Star Game and looks on track to beat last year’s fifth-place finish in MVP balloting.

Despite Tucker’s massive numbers, the Astros head into this weekend’s set against the Angels with a 28-35 record. Their efforts to dig out of that hole will be complicated by the loss of their best player for at least a week. Houston plugged Yordan Alvarez into left field tonight against Griffin Canning, freeing the DH spot for Yainer Diaz and getting Victor Caratini into the lineup at catcher. Trey Cabbage is starting in right field for the second consecutive game.

In other injury news, the Astros announced this afternoon that starters Cristian Javier and José Urquidy each underwent Tommy John surgery (X link via Chandler Rome of the Athletic). Rome had previously reported that Javier would be undergoing TJS on Thursday. Urquidy’s status wasn’t as clear. While the team announced on Wednesday that he was headed for a season-ending elbow procedure, it wasn’t known whether he’d require a full Tommy John or a modified internal brace repair. Both pitchers seem likely to be out past the 2025 All-Star Break. Urquidy, who would be a free agent after ’25, could be non-tendered next winter.

Astros To Select Nick Hernandez

By | at

The Astros announced they have selected right-hander Nick Hernandez to their roster, with left-hander Parker Mushinski optioned in a corresponding move. Righty José Urquidy, who is slated for season-ending surgery, was be transferred to the 60-day injured list to open a 40-man spot. Chandler Rome of The Athletic relayed the moves on X prior to the official announcement (link one and two).

Hernandez, 29, was just acquired from the Padres last night in a cash deal. He had signed a minor league deal with the Friars in January and has been pitching well this year. He tossed 23 2/3 innings for Triple-A El Paso with a 1.90 earned run average, despite the hitter-friendly nature of the Pacific Coast League. He may have benefitted from an 84.5% strand rate and 4% home run to flyball ratio, but he also struck out 34% of batters faced.

The Astros were intrigued enough to send some cash to San Diego and bring Hernandez back to his original organization. The Astros drafted Hernandez back in 2016 but he reached minor league free agency after the 2022 season, eventually pivoting to the Padres.

He’ll now have a chance to improve his small-sample major league stats. He tossed three innings for the Friars last year but allowed four earned runs, leaving him currently sitting on a career ERA of 12.00. He was outrighted off the roster before re-signing on a minor league deal coming into this year.

The Astros essentially had a free roster spot to use with Urquidy set to miss the rest of the year. The same is true of Cristian Javier, as he’s slated to undergo Tommy John surgery tomorrow. He’ll eventually be transferred to the 60-day IL as well, giving Houston another roster spot to work with, which could lead to another small deal or waiver claim in the near future.

Jose Urquidy To Undergo Season-Ending Elbow Surgery

By | at

The Astros announced that right-hander Jose Urquidy will undergo elbow surgery, ending his 2024 season. Houston also confirmed that righty Cristian Javier will undergo season-ending elbow surgery, as was first reported yesterday by The Athletic’s Chandler Rome. The team didn’t specify the nature of either surgery, though Rome indicated in his original report that Javier will require Tommy John surgery. Urquidy’s surgery is being performed today, so more details will likely be available once it’s completed. Javier is slated to have his procedure performed tomorrow.

Urquidy, 29, opened the season on the injured list with a forearm strain and will now miss the entire campaign. He did pitch a bit in the minor leagues on a rehab assignment last month, but he was lifted from what’ll be his final outing of the year after experiencing renewed pain in his forearm/elbow. The Astros subsequently announced that Urquidy was seeking a second opinion, which is frequently an ominous sign for injured pitchers.

When he’s been healthy enough to take the mound, Urquidy has proven himself to be a reliable rotation cog in Houston. Outside of an ugly 5.29 ERA last year in a season that was plagued by shoulder troubles, he’s posted a sub-4.00 ERA in every season of his career, leaving him with a lifetime 3.98 mark in 405 MLB frames. His 19.6% strikeout rate is three percentage points below the league average, but Urquidy has offset that with a terrific 5.8% walk rate in his career. Home runs have been an issue, as is the case  for many shorter righties with average fastball velocity, but his changeup has been an excellent pitch that’s helped him keep lefties at bay (.203/.255/.364).

Alden Gonzalez and Jeff Passan of ESPN reported earlier this week that Urquidy could be headed for Tommy John surgery — which would be the second such procedure of his career. He previously had Tommy John surgery as a minor leaguer in 2017. Urquidy has also missed time in both 2021 and 2023 due to shoulder injuries. Whether this new procedure will be a standard Tommy John operation or a newer iteration that includes augmentation from an internal brace remains to be seen.

Either way, if this indeed proves to be a UCL-related surgery, it’s quite possible it’ll end Urquidy’s tenure with the Astros entirely. He’s being paid $3.75MM this season and is arbitration-eligible for the final time this offseason. Houston would likely need to commit the same salary to Urquidy again for a 2025 season that would be mostly spent on the injured list.

Even if Urquidy were to agree to the maximum 40% pay cut permissible under the arbitration system, that’d still be a notable price to pay for a pitcher who might not make it back until late in the season — if he returns at all. If Urquidy had multiple seasons of club control remaining, the ’Stros might make that concession, but the right-hander is slated to become a free agent following the 2025 campaign anyhow. It’s always possible they’ll come to some kind of agreement on a two-year deal that’s backloaded with most of the salary falling in 2026, but the injury unfortunately renders Urquidy a clear non-tender candidate.

With regard to the 2024 season, the official losses of both Urquidy and Javier is a gut-punch for a floundering Astros club. Houston sits at 28-34, placing them seven games behind the division-leading Mariners and six games back of the third AL Wild Card spot.

Poor starting pitching has been the most prominent reason for Houston’s decline in the AL West. In addition to Urquidy and Javier, the Astros have seen Justin Verlander and Framber Valdez both spend time on the injured list. Right-handers Hunter Brown and J.P. France — the latter now on the minor league IL due to a shoulder injury — have both taken significant steps back in 2024. Rookies Spencer Arrighetti and Blair Henley have been hit hard (the latter in a single MLB spot start). Even with Ronel Blanco in the midst of a surprise breakout during his age-30 season, the Astros’ collective 4.71 rotation ERA ranks 26th in the majors.

Reinforcements should be on the horizon in the form of righties Luis Garcia and Lance McCullers Jr., though neither pitcher’s return is imminent just yet. Garcia, on the mend from Tommy John surgery performed last June, is facing live hitters and could soon head out on a minor league rehab assignment. He’d presumably require several starts before being deemed an option for the MLB rotation, however. McCullers, who had flexor surgery last summer, is a few weeks behind Garcia in his recovery process. In theory, Garcia could be back around the All-Star break, with McCullers not terribly far behind him — but that’s assuming no setbacks. And by that point, it’s also fair to wonder whether the Astros would feel the urgency to rush either pitcher.

Houston general manager Dana Brown said recently that he doesn’t envision any scenario where the Astros end up as trade deadline sellers, but it’s difficult to see how they’d be aggressive buyers if they fall much further back in the standings. There are just under eight weeks for the team to right the ship, and while a course correction is hardly implausible, the current paper-thin rotation depth means Houston will need its rotation to hold things down and perform much better while waiting on Garcia and McCullers.

Verlander, Valdez, Blanco, Brown and Arrighetti will carry on as the starting five for now, but the aforementioned Henley is the only other healthy starter on the 40-man roster. The Astros did sign lefty Eric Lauer to a minor league deal last month, and they could easily open 40-man space for him by putting Javier or Urquidy on the 60-day injured list. But Henley has been tagged for a 5.44 ERA in Triple-A this season, while Lauer was torched for seven runs over three innings in his first start with Triple-A Sugar Land. Houston can ill-afford another injury of note on the big league staff at the moment.

Jose Urquidy May Require Season-Ending Surgery

By and | at

Astros right-hander Jose Urquidy will soon see Dr. Keith Meister in Dallas and may need a second Tommy John surgery, per a report from Alden González and Jeff Passan of ESPN, relayed by González on X.

The 29-year-old Urquidy has yet to pitch this season, opening the year on the injured list with a forearm strain. He went out on a minor league rehab assignment last month, but he was pulled from his latest appearance after experiencing renewed discomfort in his forearm area. Houston skipper Joe Espada said late last week that Urquidy and fellow right-hander Cristian Javier were seeking opinions from other doctors for their respective forearm issues — always an ominous development for a pitcher when dealing with a forearm/elbow injury.

This marks the third time in four seasons that Urquidy has spent time on the injured list, though this would obviously be the most significant injury of the bunch. Shoulder troubles limited him to 20 starts and 107 innings back in 2021, and he missed more than three months of the 2023 campaign with another shoulder injury.

When healthy, Urquidy is a solid big league arm. He was tagged for a 5.29 ERA last year, perhaps due to that shoulder injury, but has otherwise posted a sub-4.00 ERA mark in every big league season he’s pitched. He’s totaled 405 MLB frames and logged a 3.98 ERA. Urquidy’s 19.6% strikeout rate is about three percentage points shy of the league average, but he’s also posted an excellent 5.8% walk rate in the majors which has helped him to offset the relative lack of whiffs. He’s been prone to homers, as one might expect from an undersized right-hander with average fastball velocity, but his changeup has been an excellent pitch that’s helped him to hold left-handers to a woeful .203/.255/.364 slash in his career.

Urquidy is one of several Houston rotation options who’s missed time this year. Both Justin Verlander and Framber Valdez are healthy now but have had stays on the injured list. The aforementioned Javier just landed on the 15-day IL recently. The ’Stros have also been without righties Luis Garcia and Lance McCullers Jr. all season, with the former recovering from Tommy John surgery performed last May and the latter on the mend from flexor surgery performed last June.

The litany of injuries, paired with major steps back for right-handers J.P. France and Hunter Brown, has left Houston in what’s been an unfamiliar position for them in recent years: one of possessing a clear deficiency in the starting rotation. Starting pitching has been a hallmark of recent Astros clubs, but Houston starters rank 26th in baseball with a 4.69 ERA in 2024.

Brown has begun to right the ship after incorporating a new two-seamer into his repertoire, but he opened the season with 26 runs in 23 innings, so he has a ways to go before his numbers look respectable once again. France posted an ERA north of 7.00 and was optioned to Triple-A, where he’s since gone on the injured list with a shoulder injury. Rookie Spencer Arrighetti has been knocked around for a 5.98 ERA in his first nine MLB starts.

The quartet of Verlander, Valdez, Javier and breakout righty Ronel Blanco has combined for strong results this season, but Javier’s outlook is up in the air at the moment. Brown is holding down a rotation spot and can hopefully continue his recent stretch of productivity, but the depth behind the current group is suspect. Expected returns of Urquidy, McCullers and Garcia have been viewed as critical to the Astros as the summer wears on, but it now seems there’s a real chance Urquidy won’t make it back to the mound at all in 2024. Lefty Eric Lauer recently inked a minor league deal with the Astros but was hit hard in his first Triple-A start with the organization.

If Urquidy does go under the knife for the second Tommy John surgery of his career, he’ll miss the remainder of the 2024 season and likely the majority of the 2025 campaign as well. It seems quite possible that a surgery would end his tenure in Houston. He entered the 2024 season with 4.049 years of MLB service and will be paid $3.75MM this season, potentially spending the entire year on the injured list. He’d then be arbitration-eligible one final time this offseason before qualifying as a free agent post-2025. However, if Urquidy is going to miss the bulk of next season, the Astros would likely non-tender him rather than pay him what’d likely be a repeat of this year’s $3.75MM salary just to pitch the final couple months of next season in a best-case scenario.

Astros Notes: Alvarez, Abreu, Rotation

By | at

Jose Abreu’s return from an optional assignment to the minor leagues will indirectly further crowd the the team’s outfield mix, writes Matt Kawahara of the Houston Chronicle. Manager Joe Espada said yesterday that with Abreu back on the roster, Yordan Alvarez is likely to see more time in left field, allowing both Abreu and Jon Singleton to be in the lineup at first base and designated hitter.

Alvarez has made consecutive starts in left field after previously appearing in only three games at the position. Espada noted that Alvarez picking up outfield at-bats will come at the expense of Chas McCormick and Mauricio Dubon, adding that he’ll still work to keep everyone involved in the mix for playing time. (MVP candidate Kyle Tucker and center fielder Jake Meyers, in the midst of a breakout showing, naturally don’t appear as though their playing time will be impacted.)

Abreu is 1-for-6 with an RBI single since being recalled from a monthlong sojourn to the minor leagues — a rare assignment for a veteran of his status but one to which the former AL MVP consented after a disastrous start to the season. He went 7-for-22 with a homer and a pair of doubles with Houston’s Rookie-level Arizona Complex League affiliate. Abreu then played a pair of games in Triple-A Sugar Land and went 0-for-7 with a walk and three strikeouts.

The Astros are trying what they can to get Abreu back on track after a disappointing debut campaign in 2023 and a calamitous .099/.156/.113 slash through his first 77 plate appearances of the current campaign. It’s not clear what kind of leash Abreu will have, particularly with Houston sitting 6.5 games back in both the AL West and in the AL Wild Card chase, but Abreu’s three-year, $58.5MM contract gives the team plenty of financial incentive to try to turn things around.

Between Abreu and the 32-year-old Singleton, who returned to the majors after a seven-year absence last season, the Astros’ first base mix has been woefully unproductive. Singleton has turned in a .221/.327/.359 slash — roughly league-average offense (102 wRC+) that’s been accompanied by poorly rated defense (-4 Defensive Runs Saved, -4 Outs Above Average in 293 innings).

That lackluster output from the team’s first basemen is just one of many reasons the Astros find themselves staring at a 24-32 record with more than a third of the season in the books. The rotation’s health — or rather, the lack thereof — has also been a prominent factor. On that front, Espada provided a mixed bag of updates.

On the positive side of things, right-hander Luis Garcia is continuing to progress well in his rehab from last year’s Tommy John surgery. He threw off a mound at Minute Maid Park last week, and MLB.com’s Brian McTaggart tweets that the right-hander is now slated to throw to hitters in his next throwing session. McTaggart adds that righty Lance McCullers Jr., who’s on the mend from flexor surgery, threw a bullpen session this week but is still “a few weeks” from facing live hitters.

Facing live hitters and pitching in simulated game settings are often the last steps before an injured pitcher is cleared to set out on a minor league rehab assignment. Garcia will presumably have multiple live batting practice sessions before progressing to a rehab stint, which could last up to 30 days itself. A return isn’t right around the corner just yet, but he’s on track for a midsummer debut this year. McCullers, it seems, isn’t terribly far behind him.

Less encouraging were Espada’s updates on injured right-handers Jose Urquidy and Cristian Javier. Both are “getting opinions from other doctors,” according to Espada (via McTaggart). Seeking second opinions is always an ominous step for a pitcher, particularly when both are dealing with this type of injury. Urquidy has yet to pitch this season after suffering a forearm strain in spring training. Javier went on the injured list last week with forearm discomfort.

AL West Notes: Abreu, Urquidy, Trout, Adams

By | at

The Astros are set to welcome first baseman Jose Abreu back into the fold in the coming days, as Abreu himself told reporters (including The Athletic’s Chandler Rome) earlier today that he’s set to fly to Seattle tomorrow ahead of the club to meet them for the club’s three-game set against the Mariners, which is set to begin on Monday. Abreu had previously been expected to join Houston in Oakland for a three game set against the A’s, but the club instead decided to get the veteran a few extra games in the minors.

Abreu, 37, struggled through a down season at the plate last year in his first season with the Astros but began to heat up somewhat late in the season, providing optimism for his second year with the club. Unfortunately, the hot stretch didn’t carry over and the veteran posted a disastrous .099/.156/.113 slash line in 22 games before agreeing to be optioned to the minors in an attempt to overcome the deep struggles that had been plaguing him. Since then, Abreu has appeared in six games in the minor leagues and slashed a respectable .280/.357/.480 in 28 trips to the plate.

If Abreu can show anything close the offensive performance he offered during his time with the White Sox, for whom he never posted a wRC+ less than 14% better than league average, it would provide a huge boost to an Astros club that has scuffled in the early going and currently sits 3.5 games out of first place in the AL West with a 23-29 record that puts them behind both the Mariners and Rangers. Jon Singleton has performed admirably at first base in Abreu’s absence with a 110 wRC+ in 38 games this year, but that includes a paltry .206/.290/.324 slash line against left-handed pitching this year. Abreu, by contrast, produced well against southpaws even last season, when he hit a decent .235/.296/.444 against them in 179 trips to the plate.

More from around the AL West…

  • Sticking with the Astros, right-hander Jose Urquidy suffered a tough setback today after exiting a rehab start due to what manager Joe Espada termed “right forearm discomfort,” as relayed by Matt Kawahara of the Houston Chronicle. Urquidy is undergoing evaluation to determine the severity of the issue, but even a brief setback would be an unfortunate turn of events for Houston. Urquidy had been expected to return to the club at some point within the next week, and in doing so would have offered the Astros some much-needed pitching depth amid deep struggles in the rotation. The club is currently utilizing a six-man rotation of Justin Verlander, Framber Valdez, Cristian Javier, Hunter Brown, Spencer Arrighetti, and Ronel Blanco, but only Blanco and Verlander have been above average by measure of ERA+ and no one in that group has posted a FIP below 4.00 this season.
  • Angels superstar Mike Trout spoke to reporters (including MLB.com’s Rhett Bollinger) prior to today’s game against the Guardians earlier today and offered an optimistic update regarding his rehab from meniscus surgery earlier this month. While Trout didn’t provide a timetable for his return, he noted that he’s “feeling good” as he regains strength in his leg while resuming weight room activity, and added that he’s “pretty close” to beginning to run again. The star center fielder was off to another great start this year prior to the injury, slashing .220/.325/.541 despite a shockingly low .194 BABIP thanks in part to a whopping 10 homers in 29 games. Reporting at the time of his surgery suggested a four-to-six week recovery period was the best case scenario for Trout’s return, although the Angels have since indicated that they’re going to take Trout’s rehab slowly in order to minimize the odds of re-injury.
  • The Athletics had a bit of a scare regarding right-hander Austin Adams earlier today in their game against Houston when he was removed from the game due to a bout of left neck tightness. Fortunately, manager Mark Kotsay told reporters (including Martin Gallegos of MLB.com) after the game this evening that Adams is day-to-day and probably could have pitched through the issue if necessary, though the club preferred not to risk it. One of several journeymen making the most of their time in Oakland, Adams has been excellent for the A’s this season as he’s pitched to a 2.65 ERA with a 3.01 FIP across 23 appearances with a whopping 32.9% strikeout rate. Adams has acted as the primary set-up man to star closer Mason Miller this season, and the 33-year-old is controlled through the end of next season, a fact that could make him a particularly attractive target at the trade deadline this summer if he can stay healthy and effective.
Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrows scroll to top